Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy

Journal of Nuclear Medicine

Volumn 40, Issue 10, 1999, Pages 1602-1608

  Lebtahi, Rachida ^a   Cadiot, Guillaume ^a   Delahaye, Nicolas ^a   Genin, Remy ^a   Daou, Doumit ^a   Peker, Muammer C ^a   Chosidow, Denis ^a   Faraggi, Marc ^a   Mignon, Michel ^a   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Bone metastases; Bone scintigraphy; Gastroenteropancreatic tumor; Somatostatin receptor scintigraphy

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ENDOCRINE TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOID TUMOR; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TECHNETIUM TC 99M MEDRONATE; ZOLLINGER-ELLISON SYNDROME;

EID: 0032887684     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mignon M, Bonfils S. Diagnosis and treatment of Zollinger Ellison syndrome, Baillière's Clin Gastroenterol. 1988;2:677-698.
2. Norton JA. Surgical treatment of islet cell tumors with special emphasis on operative ultrasound. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances. Basel, Switzerland: Karger Publishers; 1995:309-332.
3. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome. Ann Surg. 1992;215:8-18.
4. Erikson B, Skogseid, Lundqvist G, Wide L, Wilander E, Oberg K. Medical and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer. 1990;65:1883-1890.
5. Weber HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger Ellison syndrome: a prospective long term study. Gastroenterology. 1995;108:1637-1649.
6. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990;323:1246-1249.
7. 123I-Thyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
8. De Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M, and the GRESZE Study Group. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med. 1994;21:1191-1197.
9. 111indium pentetreotide scintigraphy. Semin Oncol. 1994;21:15-20.
10. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med. 1995;36:542-549.
11. Kwekkeboom DJ, Krenning EP, Oei HY, et al. Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances. Basel, Switzerland: Karger Publishers; 1995:298-308.
12. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - a prospective study. Ann Intern Med. 1996;125:26-34.
13. Lebtahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastro-enteropancreatic tumors. J Nucl Med. 1997;38:853-858.
14. Gibril F, Doppman JL, Reinolds JC, et al. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scintigraphy and magnetic resonance imaging in their detection, frequency, location and effect of their detection on management. J Clin Oncol. 1998;16:1040-1053.
15. Barton JC, Hirschowitz BI, Maton PN, Jensen RT. Bone metastases in malignant gastrinoma. Gastroenterology. 1986;91:1179-1185.
16. Pederson RT, Haidak DJ, Ferris RA, Macdonald JS, Schein PS. Osleoblastic bone metastasis in Zollinger Ellison syndrome. Radiology. 1976;118:63-64.
17. Park HM, Gudkese DB, Clark SA, Nelson R. Skeletal metastasis from gastrinoma: an uncommon manifestation of pancreatic endocrine tumor. Clin Nucl Med. 1986;11:799-800.
18. Powell JM. Metastatic carcinoid of bone: report of two cases and review of the literature. Clin Orthop. 1988;230:266-272.
19. Peavy PW, Rogers JV, Clements JL, et al. Unusual osteoblastic metastases from carcinoid tumors. Radiology. 1973;107:327-330.
20. 99mTc-pyrophosphate bone scans in patients with metastatic carcinoid tumors. J Med. 1977;8:71-80.
21. Lebtahi R, Cadiot G, Sarda L, et al. Detection of bone metastases in neuroendocrine gastroenteropancreatic (GEP) tumors: comparison of bone and somatostatin receptor scintigraphy [abstract]. J Nucl Med. 1995;36:127P.
22. Gibril F, Termanini B, Stewart CA, Sutliff VE, Jensen RT. Prospective study of the occurrence of metastases to bone in patients with Zollinger Ellison syndrome [abstract]. Gastroenterology. 1996;111:A1073.
23. Wilson MA, Calhoun FW. The distribution of skeletal metastases in breast and pulmonary cancer: concise communication. J Nucl Med. 1981;22:594-597.
24. Fogelman I, McKillop JH. The bone scan in metastastic disease. In: Rubess RD, Fogelman I, eds. Bone Metastases: Diagnosis and Treatment. London, UK: Springer-Verlag; 1991:33-61.
25. Fordham EW, Ali A. Skeletal imaging in malignant disease. In: Gottschalk A, Hoffer PB, Potchen EJ, eds. Diagnostic Nuclear Medicine. Vol. 2. 2nd ed. Baltimore, MD: Williams and Wilkins; 1988:1011-1032.